Skip to main content

DNAVision to Install Illumina HiScanSQ for GWAS Projects

Premium

This article was originally published May 17.

Belgian genomic service provider DNAVision said this week that it is purchasing an Illumina HiScanSQ microarray scanning and sequencing instrument for its Gosselies facility.

The company plans to use the new instrument initially for genome-wide association studies for its pharmaceutical and medical research customers.

The new platform, which DNAVision said will be the first HiScanSQ for commercial use in Europe, will add to the firm's existing next-gen sequencing services on the Illumina HiSeq 2000, Illumina GAIIx, and Roche 454 GS FLX, and to its array services using Illumina, Agilent, and Affymetrix microarrays.

DNAVision is ISO17025-accredited, CLIA-certified, CAP-accredited, GLP-certified, and GMP-certified.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.